#GDR -Recap and synopsis

PR isn't great but there is a lot progressing in the pipeline - Manage risk.
Beckham Coulter colab to develop a turn-key solution to step up testing.
Distribution contracts already signed in smaller countries
Product well suited to mass volume testing
#GDR
Regulatory approval: Fundamentally reg processes are negotiated well. WHO recognised HCV test, South African approval
Good clinical data achieved in laboratory trials
Indian approval in progress
WHO & FDA requested additional date in November due to requirement changes=delay
#GDR in late discussions with an EU country's MOH. If won value of contract said to be in low double-digit millions. Due Q1. Expect interest to build again in anticipation of this (keep an eye on the volume)

CE Mark is providing opportunities outside of FDA, which is for the USA
#GDR
B+C partnership gives a weighted distribution route to the USA to automate the Genedrive assay

Commercial clinical lab set up in the US working to validate swab and saliva automated platform - 15m test!

New's on supplying test to come.
#GDR
Test results can be sent direct from the Genedrive device to informative systems directly for infection tracking

WHO prequalified HCV test and Hearing loss kit receiving desired feedback from studies and NHS hospital respectively.
#GDR

Contract awards on any of the above will materially affect Market Cap. FDA delay has dramatically affected SP, but the delays to date are legitimate. Company isn't proactively working to restore immediate faith but the progress and information is there. Q1 due to be busy.
You can follow @ShareMuncher.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.